Bladou F, Houvenaeghel G, Delpéro J R, Guérinel G
Department of Surgery, Paoli-Calmettes Cancer Center, Marseille, France.
J Surg Oncol. 1995 Feb;58(2):91-6. doi: 10.1002/jso.2930580204.
Urinary fistulae and obstruction following pelvic exenteration are frequent and life-threatening complications. They increase the mortality and morbidity rates of large exereses performed during pelvic exenteration for gynecological cancers. From a series of 97 patients who underwent pelvic exenteration for gynecological cancers we report the incidence, risk factors, and management of major urinary complications. Eighty patients had had previous surgery and/or pelvic radiation therapy at the time of pelvic exenteration. A urinary diversion was performed in 63 patients. Major early urinary complications were: urinary fistula in seven patients and ureteral obstruction in four patients (11.3% of the patients). Ten patients had a late urinary complication: stenosis of the cutaneous ureteral meatus (five), stenosis of the ureteroileal anastomosis following ileal loop (two), and urinary fistulae (three). Cancer recurrence was found in 4 of these 10 cases. Major early urinary complications were significantly increased in patients who had received previous pelvic radiation therapy (P < 0.05) and in patients who had had an intestinal conduit for urinary diversion (P < 0.05). Reoperation was done in six of seven cases of early urinary fistula (urinary undiversion four, nephrectomy one, ureteral reimplantation one). Three of four ureteral obstructions were managed with percutaneous nephrostomy and ureteral stent. We recommend the use of nonirradiated bowel segment for urinary diversion as transverse colon or jejunal conduit in patients who have received previous high doses of pelvic radiotherapy. For the management of urinary complications post pelvic exenteration, reoperation is required for most urinary fistula but ureteral obstructions can be managed with percutaneous nephrostomy and ureteral stent.
盆腔脏器清除术后尿瘘和梗阻是常见且危及生命的并发症。它们增加了妇科癌症盆腔脏器清除术期间进行的大型手术的死亡率和发病率。我们从97例接受妇科癌症盆腔脏器清除术的患者系列中报告了主要泌尿系统并发症的发生率、危险因素及处理方法。80例患者在盆腔脏器清除术时曾接受过先前的手术和/或盆腔放疗。63例患者进行了尿流改道。早期主要泌尿系统并发症为:7例患者出现尿瘘,4例患者出现输尿管梗阻(占患者的11.3%)。10例患者出现晚期泌尿系统并发症:皮肤输尿管口狭窄(5例)、回肠袢式输尿管回肠吻合口狭窄(2例)和尿瘘(3例)。这10例中有4例发现癌症复发。接受过先前盆腔放疗的患者(P < 0.05)和采用肠道代膀胱进行尿流改道的患者(P < 0.05)早期主要泌尿系统并发症明显增加。7例早期尿瘘患者中有6例进行了再次手术(4例恢复原尿流通道,1例肾切除,1例输尿管再植)。4例输尿管梗阻中有3例通过经皮肾造瘘和输尿管支架治疗。我们建议在接受过先前高剂量盆腔放疗的患者中,采用未受照射的肠段如横结肠或空肠导管进行尿流改道。对于盆腔脏器清除术后泌尿系统并发症的处理,大多数尿瘘需要再次手术,但输尿管梗阻可通过经皮肾造瘘和输尿管支架治疗。